ZH

RU

ES

Biology Triple Evaluation

Biology Triple Evaluation, Total:498 items.

In the international standard classification, Biology Triple Evaluation involves: Farming and forestry, Pharmaceutics, Dentistry, Laboratory medicine, Medical equipment, Occupational safety. Industrial hygiene, Vocabularies, Pesticides and other agrochemicals, Microbiology, Products of the chemical industry, Environmental protection, Medical sciences and health care facilities in general, Biology. Botany. Zoology, Powder metallurgy, Hospital equipment, Protection against dangerous goods, Non-destructive testing, Sterilization and disinfection, Information sciences. Publishing, Soil quality. Pedology, Applications of information technology, Water quality.


Yunnan Provincial Standard of the People's Republic of China, Biology Triple Evaluation

未注明发布机构, Biology Triple Evaluation

  • DIN EN ISO 10993-18:2009 Biological assessment of medical devices
  • DIN EN ISO 10993-1:2003 Biological assessment of medical devices Part 1: Assessment and testing
  • DIN EN ISO 10993-1:1998 Biological evaluation of medical devices – Part 1: Evaluation and testing
  • BS EN ISO 10993-11:2018(2022) Biological evaluation of medical devices Part 11 : Tests for systemic toxicity
  • BS EN ISO 10993-16:2017(2020) Biological evaluation of medical devices Part 16 : Toxicokinetic study design for degradation products and leachables
  • YY 0127.6-1999 Biological evaluation of oral materials. Unit 2: Biological testing methods of oral materials. Manifest lethality test
  • YY 0127.8-2001 Biological evaluation of oral materials. Unit 2: Biological testing methods of oral materials. Subcutaneous implantation test
  • BS EN ISO 10993-1:2020 Tracked Changes. Biological evaluation of medical devices. Evaluation and testing within a risk management process
  • YY 0127.7-2017 Biological Evaluation of Oral Medical Devices Part 7: Pulp Dentin Application Test
  • BS ISO 17616:2019 Soil quality — Guidance on the choice and evaluation of bioassays for ecotoxicological characterization of soils and soil materials

Association Francaise de Normalisation, Biology Triple Evaluation

  • NF S99-501:1998 Biological evaluation of medical devices. Part 1 : evaluation and testing.
  • NF T75-600:2012 Cosmetics - Microbiology - Evaluation of the antimicrobial protection of a cosmetic product.
  • NF EN ISO 11930:2019 Cosmétiques - Microbiologie - Évaluation de la protection antimicrobienne d'un produit cosmétique
  • NF EN ISO 10993-23:2021 Evaluation biologique des dispositifs médicaux - Partie 23 : essais d'irritation
  • NF S99-501-18:2009 Biological evaluation of medical devices - Part 18 : chemical characterization of materials.
  • NF S99-501-23*NF EN ISO 10993-23:2021 Biological evaluation of medical devices - Part 23 : tests for irritation
  • FD S99-516*FD ISO/TR 37137:2014 Cardiovascular biological evaluation of medical devices - Guidance for absorbable implants
  • NF EN ISO 10993-2:2022 Évaluation biologique des dispositifs médicaux - Partie 2 : Exigences relatives à la protection des animaux
  • NF EN ISO 10993-11:2018 Évaluation biologique des dispositifs médicaux - Partie 11 : essais de toxicité systémique
  • NF EN ISO 10993-10:2023 Évaluation biologique des dispositifs médicaux - Partie 10 : essais de sensibilisation cutanée
  • NF S99-507:1996 Biological evaluation of medical devices. Part 7 : ethylene oxide sterilization residuals.
  • NF EN ISO 10993-7:2008 Évaluation biologique des dispositifs médicaux - Partie 7 : résidus de stérilisation à l'oxyde d'éthylène
  • XP ISO/TS 10993-19:2022 Évaluation biologique des dispositifs médicaux - Partie 19 : caractérisations physicochimique, morphologique et topographique des matériaux
  • NF EN ISO 10993-17:2009 Évaluation biologique des dispositifs médicaux - Partie 17 : établissement des limites admissibles des substances relargables
  • NF EN ISO 10993-12:2021 Evaluation biologique des dispositifs médicaux - Partie 12 : préparation des échantillons et matériaux de référence
  • NF S99-518:2005 Biological evaluation of medical devices - Part 18 : chemical characterization of materials.
  • NF S99-501-11:2009 Biological evaluation of medical devices - Part 11 : tests for systemic toxicity.
  • NF S99-501-11*NF EN ISO 10993-11:2018 Biological evaluation of medical devices - Part 11 : tests for systemic toxicity
  • FD S99-501-22*FD ISO/TR 10993-22:2017 Biological evaluation of medical devices - Part 22 : guidance on nanomaterials
  • NF EN ISO 11930/A1:2022 Cosmétiques - Microbiologie - Evaluation de la protection antimicrobienne d'un produit cosmétique - Amendement 1
  • FD ISO/TR 10993-22:2017 Évaluation biologique des dispositifs médicaux - Partie 22 : lignes directrices sur la nanomatériaux
  • NF EN ISO 10993-5:2010 Évaluation biologique des dispositifs médicaux - Partie 5 : essais concernant la cytotoxicité in vitro
  • NF EN ISO 10993-14:2009 Évaluation biologique des dispositifs médicaux - Partie 14 : identification et quantification des produits de dégradation des céramiques
  • NF EN ISO 10993-16:2017 Évaluation biologique des dispositifs médicaux - Partie 16 : conception des études toxicocinétiques des produits de dégradation et des substances relargables
  • NF EN 60335-2-95:2017 Évaluation biologique des dispositifs médicaux - Partie 16 : conception des études toxicocinétiques des produits de dégradation et des substances relargables
  • NF S99-501-5*NF EN ISO 10993-5:2010 Biological evaluation of medical devices - Part 5 : tests for in vitro cytotoxicity.
  • NF EN ISO 10993-6:2017 Évaluation biologique des dispositifs médicaux - Partie 6 : essais concernant les effets locaux après implantation
  • NF S99-501-16*NF EN ISO 10993-16:2017 Biological evaluation of medical devices - Part 16 : Toxicokinetic study design for degradation products and leachables
  • NF EN ISO 10993-3:2014 Évaluation biologique des dispositifs médicaux - Partie 3 : essais concernant la génotoxicité, la cancérogénicité et la toxicité sur la reproduction
  • NF S99-501-12:2012 Biological evaluation of medical devices - Part 12 : sample preparation and reference materials.
  • NF S99-501-12*NF EN ISO 10993-12:2021 Biological evaluation of medical devices - Part 12 : sample preparation and reference materials
  • NF S99-506:1995 Biological evaluation of medical devices. Part 6 : tests for local effects after implantation.
  • NF S99-501-10*NF EN ISO 10993-10:2013 Biological evaluation of medical devices - Part 10 : tests for irritation and skin sensitization
  • NF S99-501-16:2010 Biological evaluation of medical devices - Part 16 : toxicokinetic study design for degradation products and leachables.
  • NF EN ISO 10993-7/A1:2022 Evaluation biologique des dispositifs médicaux - Partie 7 : résidus de stérilisation à l'oxyde d'éthylène - Amendement 1
  • NF S99-501-3:2009 Biological evaluation of medical devices - Part 3 : tests for genotoxicity, carcinogenicity and reproductive toxicity.
  • NF S99-501-3*NF EN ISO 10993-3:2014 Biological evaluation of medical devices - Part 3 : tests for genotoxicity, carcinogenicity and reproductive toxicity
  • NF S99-503:1994 Biological evaluation of medical devices. Part 3 : tests for genotoxicity, carcinogenicity and reproductive toxicity.
  • NF EN ISO 10993-13:2010 Évaluation biologique des dispositifs médicaux - Partie 13 : identification et quantification de produits de dégradation de dispositifs médicaux à base de polymères
  • NF S99-501-9*NF EN ISO 10993-9:2021 Biological evaluation of medical devices - Part 9 : framework for identification and quantification of potential degradation products
  • NF EN ISO 10993-9:2021 Evaluation biologique des dispositifs médicaux - Partie 9 : cadre pour l'identification et la quantification des produits potentiels de dégradation
  • NF S99-501-13*NF EN ISO 10993-13:2010 Biological evaluation of medical devices - Part 13 : identification and quantification of degradation products from polymeric medical devices
  • NF S99-501-15*NF EN ISO 10993-15:2009 Biological evaluation of medical devices - Part 15 : identification and quantification of degradation products from metals and alloys
  • NF EN ISO 10993-15:2009 Évaluation biologique des dispositifs médicaux - Partie 15 : identification et quantification des produits de dégradation issus des métaux et alliages
  • NF X31-621*NF ISO 17616:2020 Soil quality - Guidance on the choice and evaluation of bioassays for ecotoxicological characterization of soils and soil materials
  • NF S99-504:1994 Biological evaluation of medical devices. Part 4 : selection of tests for interactions with blood.
  • NF S99-501-4*NF EN ISO 10993-4:2018 Biological evaluation of medical devices - Part 4 : selection of tests for interactions with blood
  • NF EN ISO 10993-4:2018 Évaluation biologique des dispositifs médicaux - Partie 4 : choix des essais pour les interactions avec le sang
  • NF EN 455-3:2015 Gants médicaux non réutilisables - Partie 3 : exigences et essais pour évaluation biologique
  • NF S91-224/A1:2013 Dentistry - Evaluation of biocompatibility of medical devices used in dentistry - Amendment 1 : positive control material

Group Standards of the People's Republic of China, Biology Triple Evaluation

  • T/SGIPA 011-2021 Evaluation standards for green pest prevention and control projects
  • T/SGIPA 009-2023 Evaluation criteria for vector green prevention and control project
  • T/CAMDI 033-2020 Guide for biological evaluation of packaging materials for medical devices
  • T/LNCPIA 002-2022 Technical specification of efficacy evaluation for degradation of triazine herbicides y biological products
  • T/FSYY 0030-2021 Production life cycle assessment specification for nickel cobalt manganese composite hydroxide
  • T/CAMDI 061-2021 Evaluation criteria for biological hazards of residual particles in metal implants manufactured by additive manufacturing
  • T/CAMDI 034-2020 Biological evaluation of medical devices Medical catheter with hydrophilic polymer coating:Sample preparation

International Organization for Standardization (ISO), Biology Triple Evaluation

  • ISO/TR 15499:2016 Biological evaluation of medical devices - Guidance on the conduct of biological evaluation within a risk management process
  • ISO/TR 7405:1984 Biological evaluation of dental materials
  • ISO/TR 15499:2012 Biological evaluation of medical devices - Guidance on the conduct of biological evaluation within a risk management process
  • ISO 10993-1:2003 Biological evaluation of medical devices - Part 1: Evaluation and testing
  • ISO 11930:2012 Cosmetics - Microbiology - Evaluation of the antimicrobial protection of a cosmetic product
  • ISO 11930:2019 Cosmetics — Microbiology — Evaluation of the antimicrobial protection of a cosmetic product
  • ISO 10993-2:2006 Biological evaluation of medical devices - Part 2: Animal welfare requirements
  • ISO 10993-2:1992 Biological evaluation of medical devices; part 2: animal welfare requirements
  • ISO 10993-2:2022 Biological evaluation of medical devices — Part 2: Animal welfare requirements
  • ISO 10993-18:2005 Biological evaluation of medical devices - Part 18: Chemical characterization of materials
  • ISO 10993-8:2000 Biological evaluation of medical devices - Part 8: Selection and qualification of reference materials for biological tests
  • ISO 10993-1:2009/Cor 11:2010 Biological evaluation of medical devices — Part 1: Evaluation and testing within a risk management process
  • ISO 10993-1:2009 Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process
  • ISO 10993-1:2018 Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process
  • ISO 10993-23:2021 Biological evaluation of medical devices - Part 23: Tests for irritation
  • ISO/TR 37137:2014 Cardiovascular biological evaluation of medical devices - Guidance for absorbable implants
  • ISO 10993-12:2021 Biological evaluation of medical devices — Part 12: Sample preparation and reference materials
  • ISO 10993-11:1993 Biological evaluation of medical devices; part 11: tests for systemic toxicity
  • ISO 10993-10:2021 Biological evaluation of medical devices — Part 10: Tests for skin sensitization
  • ISO/TS 10993-19:2020 Biological evaluation of medical devices — Part 19: Physico-chemical, morphological and topographical characterization of materials
  • ISO 7704:1985 Water quality; Evaluation of membrane filters used for microbiological analyses
  • ISO/TS 37137-1:2021 Biological evaluation of absorbable medical devices — Part 1: General requirements
  • ISO 7704:2023 Water quality — Requirements for the performance testing of membrane filters used for direct enumeration of microorganisms by culture methods
  • ISO 10993-11:2006 Biological evaluation of medical devices - Part 11: Tests for systemic toxicity
  • ISO 10993-5:1999 Biological evaluation of medical devices - Part 5: Tests for in vitro cytotoxicity
  • ISO 10993-11:2017 Biological evaluation of medical devices - Part 11: Tests for systemic toxicity
  • ISO 10993-14:2001 Biological evaluation of medical devices - Part 14: Identification and quantification of degradation products from ceramics
  • ISO 10993-6:1994 Biological evaluation of medical devices - Part 6: Tests for local effects after implantation
  • ISO 10993-7:1995 Biological evaluation of medical devices - Part 7: Ethylene oxide sterilization residuals
  • ISO 10993-7:2008 Biological evaluation of medical devices - Part 7: Ethylene oxide sterilization residuals
  • ISO 10993-7:2008/cor 1:2009 Biological evaluation of medical devices - Part 7: Ethylene oxide sterilization residuals; Technical Corrigendum 1
  • ISO 10993-3:1992 Biological evaluation of medical devices — Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity
  • ISO 10993-6:2016 Biological evaluation of medical devices - Part 6: Tests for local effects after implantation
  • ISO 10993-5:1992 Biological evaluation of medical devices — Part 5: Tests for cytotoxicity: in vitro methods
  • ISO 10993-5:2009 Biological evaluation of medical devices — Part 5: Tests for cytotoxicity: in vitro methods
  • ISO 10993-9:2009 Biological evaluation of medical devices - Part 9: Framework for identification and quantification of potential degradation products
  • ISO 10993-9:1999 Biological evaluation of medical devices - Part 9: Framework for identification and quantification of potential degradation products
  • ISO 10993-9:2019 Biological evaluation of medical devices — Part 9: Framework for identification and quantification of potential degradation products
  • ISO 10993-13:2010 Biological evaluation of medical devices - Part 13: Identification and quantification of degradation products from polymeric medical devices
  • ISO 10993-13:1998 Biological evaluation of medical devices - Part 13: Identification and quantification of degradation products from polymeric medical devices
  • ISO/TR 10993-55:2023 Biological evaluation of medical devices — Part 55: Interlaboratory study on cytotoxicity
  • ISO 10993-15:2000 Biological evaluation of medical devices - Part 15: Identification and quantification of degradation products from metals and alloys
  • ISO 17616:2019 Soil quality — Guidance on the choice and evaluation of bioassays for ecotoxicological characterization of soils and soil materials
  • ISO 10993-4:1992 Biological evaluation of medical devices — Part 4: Selection of tests for interactions with blood
  • ISO 10993-18:2020/Amd 1:2022 Biological evaluation of medical devices — Part 4: Selection of tests for interactions with blood
  • ISO/IEC TR 29198:2013 Information technology — Biometrics — Characterization and measurement of difficulty for fingerprint databases for technology evaluation
  • ISO/CD TR 37137-2 Biological evaluation of absorbable medical devices — Part 2: Standard guide for absorbable metals
  • ISO 7405:2008/Amd 1:2013 Dentistry - Evaluation of biocompatibility of medical devices used in dentistry - Amendment 1: Positive control material

国家食品药品监督管理局, Biology Triple Evaluation

  • YY/T 1512-2017 Implementation Guidelines for Biological Evaluation in the Risk Management Process of Biological Evaluation of Medical Devices
  • YY/T 1532-2017 Medical device biological evaluation nanomaterials hemolysis test
  • YY/T 1535-2017 Biological evaluation of medical devices for human in vitro assisted reproductive technology and human sperm survival test
  • YY/T 0127.13-2018 Biological evaluation of oral medical devices Part 13: Oral mucosal irritation test
  • YY/T 0719.7-2011 Ophthalmic optical contact lenses and contact lens care products - Part 7: Test methods for biological evaluation
  • YY/T 0127.7-2017 Biological Evaluation of Oral Medical Devices Part 7: Pulp Dentin Application Test

US-AAMI, Biology Triple Evaluation

  • ANSI/AAMI/ISO TIR15499:2012 Biological evaluation of medical devices - Guideance on the conduct of biological evaluation within a risk management process
  • ANSI/AAMI/ISO 10993-3:2014 Biological evaluation of medical devices. Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity
  • ANSI/AAMI/ISO 10993-1:2009 Biological evaluation of medical devices - Part 1:Evaluation and testing within a risk management process
  • ANSI/AAMI/ISO 10993-16:2017 Biological evaluation of medical devices-Part 16: Toxicokinetic study design for degradation products and leachables

VN-TCVN, Biology Triple Evaluation

  • TCVN 7391-1-2004 Biological evaluation of medical devices.Part 1: Evaluation and testing
  • TCVN 7391-18-2007 Biological evaluation of medical devices.Part 18: Chemical characterization of materials
  • TCVN 7391-2-2005 Biological evaluation of medical devices.Part 2: Animal welfare requirements
  • TCVN 7391-11-2007 Biological evaluation of medical devices.Part 11: Tests for systemic toxicity
  • TCVN 7391-12-2007 Biological evaluation of medical devices.Part 12: Sample preparation and reference materials
  • TCVN 7391-17-2007 Biological evaluation of medical devices.Part 17: Establishment of allowable limits for teachable substances
  • TCVN 7391-5-2005 Biological evaluation of medical devices.Part 5: Tests for in vitro cytotoxicity
  • TCVN 7391-6-2007 Biological evaluation of medical devices.Part 6: Tests for local effects after implantation
  • TCVN 7391-7-2004 Biological evaluation of medial devices.Part 7: Etylen oxide sterilization residuals
  • TCVN 7391-3-2005 Biological evaluation of medical devices.Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity
  • TCVN 7391-10-2007 Biological evaluation of medical devices.Part 10: Tests for irritation and delayed-type hypersensitivity
  • TCVN 7391-4-2005 Biological evaluation of medical devices.Part 4: Selection of test for interactions with blood
  • TCVN 7391-14-2007 Biological evaluation of medical devices.Part 14: Identification and quantification of degradation products from ceramics
  • TCVN 7391-16-2007 Biological evaluation of medical devices.Part 16: Toxicokinetic study design for degradation products and leachables

TH-TISI, Biology Triple Evaluation

  • TIS 2395.1-2008 Biological evaluation of medical devices.part 1: evaluation and testing
  • TIS 2395.18-2008 Biological evaluation of medical devices.part 18: chemical characterization of materials
  • TIS 2395.2-2008 Biological evaluation of medical devices.part 2: animal welfare requirements
  • TIS 2395.11-2008 Biological evaluation of medical devices.part 11: tests for systemic toxicity
  • TIS 2395.5-2008 Biological evaluation of medical devices.part 5: tests for in vitro cytotoxicity
  • TIS 2279.3-2006 Sterilization of medical devices.microbiological methods.part 3: guidance on evaluation and interpretation of bioburden data
  • TIS 2395.14-2008 Biological evaluation of medical devices.part 14: identification and quantification of degradation products from ceramics
  • TIS 2395.17-2008 Biological evaluation of medical devices.part 17: establishment of allowable limits for leachable substances
  • TIS 2395.16-2008 Biological evaluation of medical devices.part 16: toxicokinetic study design for degradation products and leachables
  • TIS 2395.6-2008 Biological evaluation of medical devices.part 6: tests for local effects after implantation
  • TIS 2395.7-2008 Biological evaluation of medical devices.part 7: ethylene oxide sterilization residuals
  • TIS 2395.12-2008 Biological evaluation of medical devices.part 12: sample preparation and reference materials
  • TIS 2395.3-2008 Biological evaluation of medical devices.part 3: tests for genotoxicity, carcinogenicity and reproductive toxicity
  • TIS 2395.9-2008 Biological evaluation of medical devices.part 9: framework for identification and quantification of potential degradation products
  • TIS 2395.4-2008 Biological evaluation of medical devices.part 4: selection of tests for interactions with blood
  • TIS 2395.15-2008 Biological evaluation of medical devices.part 15: identification and quantification of degradation products from metals and alloys
  • TIS 2395.10-2008 Biological evaluation of medical devices.part 10: tests for irritation and delayed-type hypersensitivity

General Administration of Quality Supervision, Inspection and Quarantine of the People‘s Republic of China, Biology Triple Evaluation

  • GB/T 16886.1-2001 Biological evaluation of medical devices--Part 1: Evaluation and testing
  • GB/T 16886.18-2011 Biological evaluation of medical devices.Part 18: Chemical characterization of materials
  • GB/T 16175-2008 Biological evaluation test methods for medical organic silicon materials
  • GB/T 16175-1996 Organic silicon material for medical use--Biological evaluation test methods
  • GB/T 16886.2-2000 Biological evaluation of medical devices--Part 2: Animal welfare requirements
  • GB/T 16886.2-2011 Biological evaluation of medical devices.Part 2: Animal welfare requirements
  • GB/T 16886.1-2011 Biological evaluation of medical devices.Part 1: Evaluation and testing within a risk management process
  • GB/T 16886.11-1997 Biological evaluation of medical devices--Part 11: Tests for systemic toxicity
  • GB/Z 16886.22-2022 Biological evaluation of medical devices—Part 22:Guidance on nanomaterials
  • GB/T 16886.11-2011 Biological evaluation of medical devices.Part 11: Tests for systemic toxicity
  • GB/T 16886.19-2022 Biological evaluation of medical devices—Part 19: Physico-chemical, morphological and topographical characterization of materials
  • GB/T 16886.19-2011 Biological evaluation of medical devices.Part 19: Physico-chemical,morphological and topographical characterization of materials
  • GB/T 42992.1-2023 General principles for chemical simulation tests to evaluate the biodegradability of chemicals discharged into wastewater
  • GB/T 16886.10-2000 Biological evaluation of medical devices--Part 10: Tests for irritation and sensitization
  • GB/T 16886.17-2005 Biological evaluation of medical devices.Part 17:Establishment of allowable limits for leachable substances
  • GB/T 16886.5-2017 Biological Evaluation of Medical Devices Part 5: In Vitro Cytotoxicity Tests
  • GB/T 16886.5-2003 Biological evaluation of medical devices--Part 5: Test for in vitro cytotoxicity
  • GB/T 16886.16-2013 Biological evaluation of medical devices.Part 16: Toxicokinetic study design for degradation products and leachables
  • GB/T 16886.14-2003 Biological evaluation of medical devices--Part 14: Identification and quantification of degradation products from ceramics
  • GB/T 16886.16-2003 Biological evaluation of medical devices--Part 16: Toxicokinetic study design for degradation products and leachables
  • GB/T 16886.12-2005 Biological evaluation of medical devices-Part 12:Sample preparation and reference materials
  • GB/T 16886.6-2015 Biological evaluation of medical devices.Part 6:Tests for local effects after implantation
  • GB/T 16886.7-2015 Biological evaluation of medical devices—Part 7: Ethylene oxide sterilization residuals
  • GB/T 16886.12-2000 Biological evaluation of medical devices--Part 12: Sample preparation and reference materials
  • GB/T 16886.7-2001 Biological evaluation of medical devices--Part 7:Ethylene oxide sterilization residuals
  • GB/T 16886.6-1997 Biological evaluation of medical devices--Part 6: Tests for local effects after implantation
  • GB/T 16886.3-2008 Biological evaluation of medical devices.Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity
  • GB/T 16886.3-1997 Biological evaluation of medical devices--Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity
  • GB/T 16886.9-2022 Biological Evaluation of Medical Devices Part 9: Qualitative and Quantitative Framework for Potential Degradation Products
  • GB/T 16886.9-2001 Biological evaluation of medical devices-Part 9:Framework for identification and quantification of potential degradation product
  • GB/T 16310.3-1996 Specification on evaluation methods of hazards of liquid chemicals transported in bulk by shipping--Taint testing method for aquatic organism
  • GB/T 31270.7-2014 Test guidelines on environmental safety assessment for chemical pesticides.Part 7: Bioconcentration test
  • GB/T 16886.4-2003 Biological evaluation of medical devices--Part 4: Selection of tests for interactions with blood
  • GB/T 16886.15-2022 Biological evaluation of medical devices—Part 15: Identification and quantification of degradation products from metals and alloys
  • GB/T 16886.15-2003 Biological eveluation of medical devices--Part 15: Identification and quantification of degradation products from metals and alloys
  • GB/T 16886.20-2015 Biological evaluation of medical devices.Part 20:Principles and methods for immunotoxicology testing of medical devices
  • GB/T 16310.2-1996 Specification on evaluation methods of hazards of liquid chemicals transported in bulk by shipping.Bioaccumulation testing method for aquatic organism
  • GB/T 16886.13-2001 Biological evaluation of medical devices--Part 13:Identification and quantification of degradation products from polymeric medical devices
  • GB/T 16886.10-2005 Biological evaluation of medical devices.Part 10:Tests for irritation and delayed-type hypersensitivity
  • GB/T 16310.1-1996 Specification on evaluation methods of hazards of liquid chemicals transported in bulk by shipping--Acute toxicity testing methods for aquatic organism
  • GB/T 16886.18-2022 Biological evaluation of medical devices—Part 18: Chemical characterization of medical device materials within a risk management process
  • GB/T 31270.16-2014 Test guidelines on environmental safety assessment for chemical pesticides.Part 16:Soil microorganism toxicity test

ZA-SANS, Biology Triple Evaluation

  • SANS 10993-1:2003 Biological evaluation of medical devices Part 1: Evaluation and testing
  • SANS 5233:2007 Pesticides - Biological evaluation of the efficacy of mists and fogs
  • SANS 5695:1978 Pesticides: Biological evaluation of the efficacy of mosquito repellants
  • SANS 5694:2007 Pesticides - Biological testing of the efficacy of rodenticides
  • SANS 192:1978 Pesticides: Biological evaluation of the efficacy of molluscicides
  • SANS 5693:2007 Pesticides - Biological evaluation of the efficacy of insecticide dusting powders
  • SANS 5690:2003 Pesticides - Biological evaluation of the properties of solid fly baits
  • SANS 5471:2006 Pesticides - Biological evaluation of the resistance of materials to termite attack
  • SANS 5823:1978 Pesticides: Biological evaluation of the efficacy of insecticides used on compost
  • SANS 6136:2003 Pesticides - Biological evaluation of materials that release an insecticide upon heating
  • SANS 10993-5:2003 Biological evaluation of medical devices Part 5: Tests for in vitro cytotoxicity
  • SANS 5422:2007 Pesticides - Biological evaluation of insecticidal sprays on compost (laboratory test)
  • SANS 5824:1978 Pesticides: Biological evaluation of powders that prevent decay and inhibit sprout formation in potatoes
  • SANS 5689:2002 Pesticides - Biological evaluation of knock-down and killing properties of liquid and aerosol formulations
  • SANS 5580:1969 Pesticides: Biological evaluation of mothproof textiles containing wool
  • SANS 5858:2007 Pesticides - Biological evaluation of mosquito larvicides in artificially created mosquito breeding places
  • SANS 5327:1978 Pesticides: Comparative biological evaluation of the susceptibility of two strains of house-flies to insecticides
  • SANS 10993-3:2004 Biological evaluation of medical devices Part 3: Test for genotoxicity, carcinogenicity and reproductive toxicity
  • SANS 5581:1978 Pesticides: Biological evaluation of wash-durability properties of mothproof textiles containing wool
  • SANS 10993-4:2004 Biological evaluation of medical devices Part 4: Selection of tests for interactions with blood
  • SANS 5857:1976 Pesticides: Biological evaluation of mothproof textiles containing wool after exposure to artificial sunlight
  • SANS 5582:1978 Pesticides: Biological evaluation of dry-cleaning-durability properties of mothproof textiles containing wool
  • SANS 5696:1978 Pesticides: Biological evaluation of the efficacy of residual sprays against skin and hide beetles
  • SANS 10993-10:2004 Biological evaluation of medical devices Part 10: Tests for irritation and delayed-type hypersensitivity

Professional Standard - Environmental Protection, Biology Triple Evaluation

  • HJ 623~628-2011 "Regional Biodiversity Evaluation Standards" and other six standards

British Standards Institution (BSI), Biology Triple Evaluation

  • BS PD ISO/TR 15499:2016 Biological evaluation of medical devices. Guidance on the conduct of biological evaluation within a risk management process
  • BS EN ISO 10993-2:2022 Biological evaluation of medical devices - Animal welfare requirements
  • PD ISO/TR 10993-22:2017 Biological evaluation of medical devices. Guidance on nanomaterials
  • PD ISO/TR 15499:2016 Tracked Changes. Biological evaluation of medical devices. Guidance on the conduct of biological evaluation within a risk management process
  • BS PD ISO/TS 37137-1:2021 Biological evaluation of absorbable medical devices. General requirements
  • BS EN ISO 11930:2019+A1:2022 Cosmetics. Microbiology. Evaluation of the antimicrobial protection of a cosmetic product
  • PD ISO/TS 37137-1:2021 Biological evaluation of absorbable medical devices. General requirements
  • PD ISO/TS 10993-19:2020 Biological evaluation of medical devices. Physico-chemical, morphological and topographical characterization of materials
  • PD ISO/TS 21726:2019 Biological evaluation of medical devices. Application of the threshold of toxicological concern (TTC) for assessing biocompatibility of medical device constituents
  • PD ISO/TR 37137:2014 Cardiovascular biological evaluation of medical devices. Guidance for absorbable implants
  • BS EN ISO 10993-16:2017 Biological evaluation of medical devices - Toxicokinetic study design for degradation products and leachables
  • BS EN ISO 10993-12:2012 Biological evaluation of medical devices. Sample preparation and reference materials
  • BS EN ISO 11930:2012 Cosmetics. Microbiology. Evaluation of the antimicrobial protection of a cosmetic product
  • BS PD ISO/TR 37137:2014 Cardiovascular biological evaluation of medical devices. Guidance for absorbable implants
  • BS EN ISO 10993-14:2009 Biological evaluation of medical devices - Identification and quantification of degradation products from ceramics
  • BS EN ISO 10993-17:2009 Biological evaluation of medical devices. Establishment of allowable limits for leachable substances
  • BS EN ISO 10993-7:2008+A1:2022 Tracked Changes. Biological evaluation of medical devices. Ethylene oxide sterilization residuals
  • BS EN ISO 10993-11:2018 Biological evaluation of medical devices. Tests for systemic toxicity
  • BS EN ISO 10993-6:2009 Biological evaluation of medical devices. Tests for local effects after implantation
  • BS EN ISO 10993-10:2010 Biological evaluation of medical devices. Tests for irritation and skin sensitization
  • BS EN ISO 10993-10:2023 Tracked changes. Biological evaluation of medical devices. Tests for skin sensitization
  • BS EN 29073-3:1992 Biological evaluation of medical devices. Framework for identification and quantification of potential degradation products
  • PD ISO/TR 10993-55:2023 Biological evaluation of medical devices. Interlaboratory study on cytotoxicity
  • BS EN ISO 10993-13:2010 Biological evaluation of medical devices. Part 13: Identification and quantification of degradation products from polymeric medical devices
  • 20/30398724 DC BS EN ISO 10993-2. Biological evaluation of medical devices. Part 2. Animal welfare requirements
  • 21/30379304 DC BS EN ISO 10993-17. Biological evaluation of medical devices - Part 17. Toxicological risk assessment of medical device constituents
  • DD ISO/TS 10993-20:2006 Biological evaluation of medical devices. Principles and methods for immunotoxicology testing of medical devices
  • 21/30444665 DC BS EN ISO 11930 AMD1. Cosmetics. Microbiology. Evaluation of the antimicrobial protection of a cosmetic product
  • PD ISO/TR 10993-33:2015 Biological evaluation of medical devices. Guidance on tests to evaluate genotoxicity. Supplement to ISO 10993-3
  • BS EN ISO 10993-12:2021 Tracked Changes. Biological evaluation of medical devices. Sample preparation and reference materials
  • BS EN ISO 10993-6:2016 Tracked Changes. Biological evaluation of medical devices. Tests for local effects after implantation
  • BS EN ISO 10993-3:2014 Biological evaluation of medical devices. Tests for genotoxicity, carcinogenicity and reproductive toxicity
  • BS EN ISO 10993-11:2009 Biological evaluation of medical devices - Part 11:Tests for systemic toxicity (ISO 10993-11:2006)
  • 19/30372368 DC BS EN ISO 10993-23. Biological evaluation of medical devices. Part 23. Tests for irritation
  • BS EN ISO 10993-9:2021 Tracked Changes. Biological evaluation of medical devices. Framework for identification and quantification of potential degradation products
  • 20/30377819 DC BS EN ISO 10993-10. Biological evaluation of medical devices. Part 10. Tests for skin sensitization
  • BS EN ISO 10993-5:2009 Biological evaluation of medical devices - Part 5: Tests for in vitro cytotoxicity (ISO 10993-5:2009)
  • 22/30427685 DC BS EN 455-3. Medical gloves for single use. Part 3. Requirements and testing for biological evaluation
  • 17/30344601 DC BS EN ISO 10993-1. Biological evaluation of medical devices. Part 1. Evaluation and testing within a risk management process
  • 16/30343252 DC BS EN 455-3 AMD1. Medical gloves for single use. Part 3. Requirements and testing for biological evaluation

GOSTR, Biology Triple Evaluation

  • GOST R 58483-2019 Rodenticides. Methods for biological performance evaluations
  • GOST ISO/TR 10993-33-2018 Medical levices. Biological evaluation of medical devices. Part 33. Guidance on tests to evaluate genotoxicity. Supplement to ISO 10993-3
  • GOST ISO/TR 10993-22-2020 Medical devices. Biological evaluation of medical devices. Part 22. Guidance on nanomaterials

Japanese Industrial Standards Committee (JISC), Biology Triple Evaluation

  • JIS T 0993-1:2005 Biological evaluation of medical devices -- Part 1: Evaluation and testing
  • JIS T 0993-1:2012 Biological evaluation of medical devices -- Part 1: Evaluation and testing within a risk management process
  • JIS T 0993-7:2012 Biological evaluation of medical devices -- Part 7: Ethylene oxide sterilization residuals

Professional Standard - Medicine, Biology Triple Evaluation

  • YY/T 0268-2008 Dentistry.Biological evaluation of medical devices used in dentistry.Part 1:Evaluation and test
  • YY/T 0268-2001 Dentistry----Preclinical evaluation of biocompatibility of medical devices used in dentistry----Part 1:Evaluation and test methods selection
  • YY/T 1912-2023 Biological evaluation and testing of medical devices for soft tissue regeneration
  • YY/T 1815-2022
  • YY/T 0127.11-2014 Biological evaluation of medical devices used in dentistry.Part 11:Pulp capping test
  • YY/T 0616-2007 Medical gloves for single use.Requirements and testing for biological evaluation
  • YY/T 1295-2015 Biological evaluation of medical devices.Nanomaterial: Endotoxin test
  • YY 0719.7-2011 Ophthalmic optics.Contact lens care products.Part 7:Biological evaluation test methods
  • YY/T 0127.4-1998 Biological evaluation of dental materials.Unit2:Biological evaluation method of dental materials.Bone implant test
  • YY/T 0127.5-2014 Biological evaluation of medical devices used in dentistry.Part 5:Inhalation toxicity test
  • YY/T 0127.5-1999 Biological evaluation of dental materials.Unit 2:Biological test methods of dental materials.Inhalation toxicity test
  • YY/T 0127.6-1999 Biological evaluation of dental materials.Unit 2:Biological test methods of dental materials.Dominant lethal test
  • YY/T 0127.8-2001 Biological evaluation of dental materials.Part 2:Biological evaluation test method of dental materials.Subcutaneous implant test
  • YY/T 0127.12-2008 Dentistry.Biological evaluation of medical devices used in dentistry Part 2:Test method.Micronucleus test
  • YY/T 0127.3-2014 Biological evaluation of medical devices used in dentistry.Part 3: Endodontic usage test
  • YY/T 0127.3-1998 Biological evaluation of dental materials.Unit 2:Biological evaluation method of dental materials。Endodontic usage test
  • YY/T 0616.1-2016 Medical gloves for single use.Part 1:Requirements and testing for biological evaluation
  • YY/T 0127.7-2001 Biological evaluation of of dental materials.Part 2:Biological evaluation test method of dental materials.Pulp and dentine usage test
  • YY/T 0127.4-2009 Biological evaluation of medical devices used in dentistry.Part 2:Test method Bone implant test
  • YY/T 1897-2023 Biological evaluation of nanomedical devices Genotoxicity test In vitro mammalian cell micronucleus test
  • YY/T 0127.18-2016 Biological evaluation of medical devices used in dentistry.Part 18:Dentine barrier cytotoxicity test
  • YY/T 0127.13-2009 Biological evaluation of medical devices used in dentistry.Part 2:Test method.Oral mucous membrane irritation test

CEN - European Committee for Standardization, Biology Triple Evaluation

  • EN ISO 11930:2012 Cosmetics - Microbiology - Evaluation of the antimicrobial protection of a cosmetic product
  • EN ISO 11930:2019 Cosmetics - Microbiology - Evaluation of the antimicrobial protection of a cosmetic product
  • EN ISO 10993-18:2009 Biological evaluation of medical devices - Part 18: Chemical characterization of materials
  • EN ISO 10993-18:2005 Biological evaluation of medical devices - Part 18: Chemical characterization of materials
  • EN ISO 10993-11:2006 Biological evaluation of medical devices - Part 11: Tests for systemic toxicity
  • EN ISO 10993-11:2009 Biological evaluation of medical devices - Part 11: Tests for systemic toxicity
  • EN ISO 10993-6:2009 Biological evaluation of medical devices - Part 6: Tests for local effects after implantation
  • EN ISO 10993-6:2007 Biological evaluation of medical devices - Part 6: Tests for local effects after implantation
  • EN ISO 10993-14:2001 Biological Evaluation of Medical Devices - Part 14: Identification and Quantification of Degradation Products from Ceramics
  • EN ISO 10993-14:2009 Biological evaluation of medical devices - Part 14: Identification and quantification of degradation products from ceramics
  • EN ISO 10993-9:2021 Biological Evaluation of Medical Devices - Part 9: Framework for Identification and Quantification of Potential Degradation Products
  • EN ISO 10993-9:1999 Biological Evaluation of Medical Devices - Part 9: Framework for Identification and Quantification of Potential Degradation Products
  • EN ISO 10993-9:2009 Biological evaluation of medical devices - Part 9: Framework for identification and quantification of potential degradation products

Korean Agency for Technology and Standards (KATS), Biology Triple Evaluation

  • KS M ISO 11930:2020 Cosmetics — Microbiology — Evaluation of the antimicrobial protection of a cosmetic product
  • KS P ISO 10993-2-2010(2021) Biological evaluation of medical devices-Part 2:Animal welfare requirements
  • KS P ISO 10993-2-2010(2016) Biological evaluation of medical devices-Part 2:Animal welfare requirements
  • KS P ISO 10993-18-2009(2019) Biological evaluation of medical devices-Part 18:Chemical characterization of materials
  • KS P ISO TS 20993-2009(2014) Biological evaluation of medical devices-Guidance on a risk-management process
  • KS P ISO 10993-11-2007(2017) Biological evaluation of medical devices-Part 11:Tests for systemic toxicity
  • KS P ISO 10993-7:2017 Biological evaluation of medical devices-Part 7:Ethylene oxides sterilization residuals
  • KS P ISO 10993-8:2002 Biological evaluation of medical devices-Part 8:Selection and qualification of reference materials for biological tests
  • KS P ISO 10993-8:2007 Biological evaluation of medical devices-Part 8:Selection and qualification of reference materials for biological tests
  • KS P ISO 10993-19-2009(2019) Biological evaluation of medical devices-Part 19:Physico-chemical, morphological and topographical characterization of materials
  • KS P ISO 10993-11:2021 Biological evaluation of medical devices —Part 11: Tests for systemic toxicity
  • KS P ISO TS 10993-19:2021 Biological evaluation of medical devices —Part 19: Physico-chemical, morphological and topographical characterization of materials
  • KS P ISO 10993-16:2017 Biological evaluation of medical devices — Part16:Toxicokinetic study design for degradation products and leachables
  • KS P ISO 10993-16:2021 Biological evaluation of medical devices —Part 16: Toxicokinetic study design for degradation products and leachables
  • KS P ISO 10993-15-2006(2016) Biological evaluation of medical devices-Part 15:Identification and quantification ofdegradation products from metals and alloys
  • KS P ISO 10993-9:2021 Biological evaluation of medical devices — Part 9: Framework for identification and quantification of potential degradation products
  • KS P ISO 10993-20-2009(2019) Biological evaluation of medical devices-Part 20:Principles and methods for immunotoxicology testing of medical devices
  • KS P ISO 10993-4:2017 Biological evaluation of medical devices-Part 4:Selection of tests for interactions with blood
  • KS P ISO 10993-15:2021 Biological evaluation of medical devices — Part 15: Identification and quantification of degradation products from metals and alloys
  • KS I ISO 17616-2009(2019) Soil quality-Guidance on the choice and evaluation of bioassays for ecotoxicological characterization of soils and soil materials
  • KS I ISO 9509-2008(2018) Water quality-Method for assessing the inhibition of nitrification of activated sludge micro organisms by chemicals and wastewaters
  • KS P ISO 10993-4:2021 Biological evaluation of medical devices —Part 4: Selection of tests for interactions with blood

KR-KS, Biology Triple Evaluation

  • KS M ISO 11930-2020 Cosmetics — Microbiology — Evaluation of the antimicrobial protection of a cosmetic product
  • KS P ISO 10993-23-2022 Biological evaluation of medical devices — Part 23: Tests for irritation
  • KS P ISO 10993-7-2017 Biological evaluation of medical devices-Part 7:Ethylene oxides sterilization residuals
  • KS P ISO 10993-8-2002 Biological evaluation of medical devices-Part 8:Selection and qualification of reference materials for biological tests
  • KS P ISO 10993-7-2022 Biological evaluation of medical devices — Part 7: Ethylene oxide sterilization residuals
  • KS P ISO 10993-11-2021 Biological evaluation of medical devices —Part 11: Tests for systemic toxicity
  • KS P ISO 10993-10-2022 Biological evaluation of medical devices — Part 10: Tests for skin sensitization
  • KS P ISO TS 10993-19-2021 Biological evaluation of medical devices —Part 19: Physico-chemical, morphological and topographical characterization of materials
  • KS P ISO 10993-16-2017 Biological evaluation of medical devices — Part16:Toxicokinetic study design for degradation products and leachables
  • KS P ISO 10993-14-2017 Biological evaluation of medical devices — Part14:Identification and quantification of degradation products from ceramics
  • KS P ISO 10993-16-2021 Biological evaluation of medical devices —Part 16: Toxicokinetic study design for degradation products and leachables
  • KS P ISO 10993-14-2017(2022) Biological evaluation of medical devices — Part14:Identification and quantification of degradation products from ceramics
  • KS P ISO 10993-9-2021 Biological evaluation of medical devices — Part 9: Framework for identification and quantification of potential degradation products
  • KS P ISO 10993-4-2017 Biological evaluation of medical devices-Part 4:Selection of tests for interactions with blood
  • KS P ISO 10993-15-2021 Biological evaluation of medical devices — Part 15: Identification and quantification of degradation products from metals and alloys
  • KS P ISO 10993-4-2021 Biological evaluation of medical devices —Part 4: Selection of tests for interactions with blood

Xizang Provincial Standard of the People's Republic of China, Biology Triple Evaluation

  • DB54/T 0274.2-2023 Part 2 of the Earth’s Third Pole Brand Evaluation System: Plateau Bio Brand Evaluation Requirements

Professional Standard - Aquaculture, Biology Triple Evaluation

  • SC/T 9110-2007 Technical regulations for impact assessment of construction projects on marine living resources

PT-IPQ, Biology Triple Evaluation

  • NP EN ISO 10993-1:2001 Biological evaluation of medical devices Part 1:Evaluation and testing(ISO 10993-1:1997)
  • NP EN ISO 10993-13:2000 Biological evaluation of medical devices Part 13:Identification and quantification of degradation products from polymeric medical devices(ISO 10993-13-1998)
  • NP EN ISO 10993-2:2000 Biological evaluation of medical devices Part 2:Animal welfare requirements(ISO 10993-2-1992)
  • NP EN ISO 10993-9:2001 Biological evaluation of medical devices Part 9:Framework for identification and quantification of potential degradation products(ISO 10993-9-1999)

RU-GOST R, Biology Triple Evaluation

  • GOST ISO 10993-1-2011 Medical devices. Biological evaluation of medical devices. Part 1. Evaluation and testing
  • GOST 31576-2012 Evaluation of biological hazard of medical dental materials and articles. Classification and sampling
  • GOST R ISO 10993.3-1999 Biological evaluation of medical devices. Part 3. Tests of genotoxicity, carcinogenicity and reproductive toxicity / Note: To be replaced by GOST R ISO 10993-3 (2009).
  • GOST ISO 10993-18-2011 Medical devices. Biological evaluation of medical devices. Part 18. Chemical characterization of materials
  • GOST ISO/TS 10993-19-2011 Medical devices. Biological evaluation of medical devices. Part 19. Tests physico-chemical, morphological and topographical characterization of materials
  • GOST ISO 10993-12-2015 Medical devices. Biological evaluation of medical devices. Part 12. Sample preparation and reference materials
  • GOST R ISO 10993.7-1999 Medical devices. Biological evaluation of medical devices. Part 7. Ethylene oxide sterilization residuals
  • GOST ISO 10993-7-2011 Medical devices. Biological evaluation of medical devices. Part 7. Ethylene oxide sterilization residuals
  • GOST R ISO 10993-12-1999 Medical devices. Biological evaluation of medical devices. Part 12. Sample preparation and reference materials
  • GOST ISO 10993-16-2011 Medical devices. Biological evaluation of medical devices. Part 16. Toxicokinetic study design for degradation products and leachables
  • GOST ISO 10993-11-2011 Medical devices. Biological evaluation of medical devices. Part 11. Tests for systemic toxicity
  • GOST R ISO 10993-11-1999 Medical devices. Biological evaluation of medical devices. Part 11. Tests for systemic to xicity
  • GOST ISO 10993-16-2016 Medical devices. Biological evaluation of medical devices. Part 16. Toxicokinetic study design for degradation products and leachables
  • GOST R ISO 10993-10-1999 Medical devices. Biological evaluation of medical devices. Part 10. Tests for irritation and sensitization
  • GOST R ISO 10993.16-1999 Medical devices. Biological evaluation of medical devices. Part 16. Toxicokinetic study design for degradation products and leachables
  • GOST ISO 10993-5-2011 Medical devices. Biological evaluation of medical devices. Part 5. Tests for in vitro cytotoxicity
  • GOST ISO 10993-7-2016 Medical devices. Biological evaluation of medical devices. Part 7. Ethylene oxide sterilization residuals
  • GOST ISO 10993-17-2011 Medical devices. Biological evaluation of medical devices. Part 17. Establishment of allowable limits for leachable substances
  • GOST ISO 10993-14-2011 Medical devices. Biological evaluation of medical devices. Part 14. Identification and quantification of degradation products from ceramics
  • GOST ISO 10993-6-2011 Medical devices. Biological evaluation of medical devices. Part 6. Tests for local effects after implantation
  • GOST ISO 10993-12-2011 Medical devices. Biological evaluation of medical devices. Part 12. Sample preparation and control materials
  • GOST R ISO 10993-6-1999 Medical devices. Biological evaluation of medical devices. Part 6. Tests for local effects after implantation
  • GOST R ISO 10993-14-2001 Medical devices. Biological evaluation of medical devices. Part 14. Identification and quantification of degradation products from ceramics

Standard Association of Australia (SAA), Biology Triple Evaluation

国家市场监督管理总局、中国国家标准化管理委员会, Biology Triple Evaluation

  • GB/T 38484-2020 Determination of the biological activity for plant hormone-related secondary metabolites—Cytological method
  • GB/T 16886.1-2022 Biological evaluation of medical devices—Part 1: Evaluation and testing within a risk management process
  • GB/T 16886.11-2021 Biological evaluation of medical devices—Part 11: Tests for systemic toxicity
  • GB/T 16886.16-2021 Biological evaluation of medical devices—Part 16: Toxicokinetic study design for degradation products and leachables
  • GB/T 16886.6-2022 Biological evaluation of medical devices—Part 6:Tests for local effects after implantation
  • GB/T 16886.3-2019 Biological evaluation of medical devices—Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity
  • GB/T 16886.4-2022 Biological evaluation of medical devices—Part 4: Selection of tests for interactions with blood

German Institute for Standardization, Biology Triple Evaluation

  • DIN EN ISO 10993-2:2023-02 Biological evaluation of medical devices - Part 2: Animal welfare requirements (ISO 10993-2:2022); German version EN ISO 10993-2:2022
  • DIN EN ISO 10993-17:2021-12 Biological evaluation of medical devices - Part 17: Toxicological risk assessment of medical device constituents (ISO/DIS 10993-17:2021); German and English version prEN ISO 10993-17:2021 / Note: Date of issue 2021-11-12*Intended as replacement for DIN...
  • DIN EN ISO 10993-1:2010 Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management system (ISO 10993-1:2009); German version EN ISO 10993-1:2009
  • DIN EN ISO 10993-10:2023-04 Biological evaluation of medical devices - Part 10: Tests for skin sensitization (ISO 10993-10:2021); German version EN ISO 10993-10:2023
  • DIN EN ISO 10993-11:2018-09 Biological evaluation of medical devices - Part 11: Tests for systemic toxicity (ISO 10993-11:2017); German version EN ISO 10993-11:2018
  • DIN EN ISO 10993-18:2005 Biological evaluation of medical devices - Part 18: Chemical characterization of materials (ISO 10993-18:2005); German version EN ISO 10993-18:2005
  • DIN EN ISO 10993-2:2023 Biological evaluation of medical devices - Part 2: Animal welfare requirements (ISO 10993-2:2022)
  • DIN EN ISO 10993-5:2009-10 Biological evaluation of medical devices - Part 5: Tests for in vitro cytotoxicity (ISO 10993-5:2009); German version EN ISO 10993-5:2009
  • DIN EN ISO 10993-1:2017 Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process (ISO/DIS 10993-1:2017); German and English version prEN ISO 10993-1:2017
  • DIN EN ISO 10993-16:2018-02 Biological evaluation of medical devices - Part 16: Toxicokinetic study design for degradation products and leachables (ISO 10993-16:2017); German version EN ISO 10993-16:2017
  • DIN EN ISO 10993-6:2017-09 Biological evaluation of medical devices - Part 6: Tests for local effects after implantation (ISO 10993-6:2016); German version EN ISO 10993-6:2016
  • DIN EN ISO 10993-12:2021-08 Biological evaluation of medical devices - Part 12: Sample preparation and reference materials (ISO 10993-12:2021); German version EN ISO 10993-12:2021
  • DIN EN 455-3:2022-03 Medical gloves for single use - Part 3: Requirements and testing for biological evaluation; German and English version prEN 455-3:2022 / Note: Date of issue 2022-02-04*Intended as replacement for DIN EN 455-3 (2015-07).
  • DIN EN ISO 10993-14:2009-08 Biological evaluation of medical devices - Part 14: Identification and quantification of degradation products from ceramics (ISO 10993-14:2001); German version EN ISO 10993-14:2009 / Note: DIN EN ISO 10993-14 (2002-05) remains valid alongside this stan...
  • DIN EN ISO 10993-17:2009-08 Biological evaluation of medical devices - Part 17: Establishment of allowable limits for leachable substances (ISO 10993-17:2002); German version EN ISO 10993-17:2009 / Note: DIN EN ISO 10993-17 (2003-06) remains valid alongside this standard until 20...
  • DIN EN ISO 10993-3:2015-02 Biological evaluation of medical devices - Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity (ISO 10993-3:2014); German version EN ISO 10993-3:2014
  • DIN EN ISO 10993-23:2021-10 Biological evaluation of medical devices - Part 23: Tests for irritation (ISO 10993-23:2021); German version EN ISO 10993-23:2021
  • DIN EN 455-3:2022 Medical gloves for single use - Part 3: Requirements and testing for biological evaluation; German and English version prEN 455-3:2022
  • DIN EN ISO 10993-11:2018 Biological evaluation of medical devices - Part 11: Tests for systemic toxicity (ISO 10993-11:2017)
  • DIN EN ISO 10993-10:2023 Biological evaluation of medical devices - Part 10: Tests for skin sensitization (ISO 10993-10:2021)
  • DIN EN 455-3:2015-07 Medical gloves for single use - Part 3: Requirements and testing for biological evaluation; German version EN 455-3:2015 / Note: To be replaced by DIN EN 455-3 (2022-03).*To be amended by DIN EN 455-3/A1 (2016-11).
  • DIN EN ISO 10993-23:2019 Biological evaluation of medical devices - Part 23: Tests for irritation (ISO/DIS 10993-23:2019); German and English version prEN ISO 10993-23:2019
  • DIN EN ISO 10993-16:2018 Biological evaluation of medical devices - Part 16: Toxicokinetic study design for degradation products and leachables (ISO 10993-16:2017)
  • DIN EN ISO 10993-14:2009 Biological evaluation of medical devices - Part 14: Identification and quantification of degradation products from ceramics (ISO 10993-14:2001)

Professional Standard - Forestry, Biology Triple Evaluation

  • LY/T 2242-2014 Technical regulation for biodiversity impact assessment of construction project in nature reserve

Beijing Provincial Standard of the People's Republic of China, Biology Triple Evaluation

  • DB11/T 1821-2021 Technical Guidelines for Environmental Impact Assessment of Construction Projects Manufacturing of Biopharmaceutical Products

PH-BPS, Biology Triple Evaluation

  • PNS ISO 10993-2:2021 Biological evaluation of medical devices - Part 2: Animal welfare requirements
  • PNS ISO 10993-7:2021 Biological evaluation of medical devices - Part 7: Ethylene oxide sterilization residuals
  • PNS ISO 10993-11:2021 Biological evaluation of medical devices - Part 11: Tests for systemic toxicity
  • PNS ISO 10993-5:2021 Biological evaluation of medical devices - Part 5: Tests for in vitro cytotoxicity
  • PNS ISO 10993-10:2021 Biological evaluation of medical devices - Part 10: Tests for irritation and skin sensitization
  • PNS ISO 10993-3:2021 Biological evaluation of medical devices - Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity
  • PNS ISO 10993-6:2021 Biological evaluation of medical devices - Part 6: Tests for local effects after implantation
  • PNS ISO 10993-9:2021 Biological evaluation of medical devices - Part 9: Framework for identification and quantification of potential degradation products
  • PNS ISO 10993-4:2021 Biological evaluation of medical devices - Part 4: Selection of tests for interactions with blood

European Committee for Standardization (CEN), Biology Triple Evaluation

  • EN ISO 10993-18:2020 Biological evaluation of medical devices - Part 18: Chemical characterization of medical device materials within a risk management process (ISO 10993-18:2020)
  • EN ISO 10993-8:2000 Biological Evaluation of Medical Devices - Part 8: Selection and Qualification of Reference Materials for Biological Tests ISO 10993-8:2000
  • EN ISO 11930:2019/A1:2022 Cosmetics - Microbiology - Evaluation of the antimicrobial protection of a cosmetic product - Amendment 1 (ISO 11930:2019/Amd 1:2022)
  • EN ISO 10993-23:2021 Biological evaluation of medical devices - Part 23: Tests for irritation (ISO 10993-23:2021)
  • EN 15354:2022 Biological evaluation of medical devices - Part 2: Animal welfare requirements (ISO 10993-2:2022)
  • EN 12929-2:2015+A1:2022 Biological evaluation of medical devices - Part 2: Animal welfare requirements (ISO 10993-2:2022)
  • EN ISO 10993-11:2018 Biological evaluation of medical devices - Part 11: Tests for systemic toxicity
  • EN ISO 10993-11:1995 Biological Evaluation of Medical Devices - Part 11: Tests for Systemic Toxicity (ISO 10993-11 : 1993)
  • EN ISO 7704:2023 Water quality - Requirements for the performance testing of membrane filters used for direct enumeration of microorganisms by culture methods (ISO 7704:2023)
  • FprEN ISO 10993-17 Biological evaluation of medical devices - Part 17: Toxicological risk assessment of medical device constituents (ISO/FDIS 10993-17:2023)
  • EN ISO 10993-18:2020/prA1:2021 Biological evaluation of medical devices - Part 18: Chemical characterization of medical device materials within a risk management process - Amendment 1: Determination of the uncertainty factor (ISO 10993-18:2020/DAM 1:2021)
  • FprEN ISO 10993-10:2021 Biological evaluation of medical devices - Part 10: Tests for skin sensitization (ISO/FDIS 10993-10:2021)
  • EN ISO 10993-6:2016 Biological evaluation of medical devices - Part 6: Tests for local effects after implantation
  • CEN EN ISO 10993-12:2004 Biological Evaluation of Medical Devices - Part 12: Sample Preparation and Reference Materials ISO 10993-12:2002

IT-UNI, Biology Triple Evaluation

  • UNI EN ISO 10993-1:2021 Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process
  • UNI EN ISO 10993-23:2021 Biological evaluation of medical devices - Part 23: Tests for irritation
  • UNI EN ISO 10993-12:2021 Biological evaluation of medical devices - Part 12: Sample preparation and reference materials
  • UNI EN ISO 10993-18:2021 Biological evaluation of medical devices - Part 18: Chemical characterization of medical device materials within a risk management process

Danish Standards Foundation, Biology Triple Evaluation

  • DS/ISO 10993-23:2021 Biological evaluation of medical devices – Part 23: Tests for irritation
  • DS/ISO/TR 10993-22:2021 Biological evaluation of medical devices – Part 22: Guidance on nanomaterials
  • DS/ISO 10993-12:2021 Biological evaluation of medical devices – Part 12: Sample preparation and reference materials
  • DS/EN ISO 10993-12:2012 Biological evaluation of medical devices - Part 12: Sample preparation and reference materials
  • DS/ISO/TS 37137-1:2021 Biological evaluation of absorbable medical devices – Part 1: General requirements
  • DS/ISO 10993-1:2020 Biological evaluation of medical devices – Part 1: Evaluation and testing within a risk management process (ISO/FDIS 10993-1:2018)
  • DS/EN ISO 10993-23:2021 Biological evaluation of medical devices – Part 23: Tests for irritation (ISO 10993-23:2021)
  • DS/EN ISO 10993-12:2021 Biological evaluation of medical devices – Part 12: Sample preparation and reference materials (ISO 10993-12:2021)
  • DS/ISO 10993-9:2021 Biological evaluation of medical devices – Part 9: Framework for identification and quantification of potential degradation products
  • DS/EN 455-3:2007 Medical gloves for single use - Part 3: Requirements and testing for biological evaluation
  • DS/EN ISO 10993-1:2020 Biological evaluation of medical devices – Part 1: Evaluation and testing within a risk management process (ISO 10993-1:2018, including corrected version 2018-11)
  • DS/EN ISO 10993-9:2021 Biological evaluation of medical devices – Part 9: Framework for identification and quantification of potential degradation products (ISO 10993-9:2019)

ES-UNE, Biology Triple Evaluation

  • UNE-EN ISO 10993-23:2021 Biological evaluation of medical devices - Part 23: Tests for irritation (ISO 10993-23:2021)
  • UNE-EN ISO 10993-2:2023 Biological evaluation of medical devices - Part 2: Animal welfare requirements (ISO 10993-2:2022)
  • UNE-EN ISO 10993-11:2018 Biological evaluation of medical devices - Part 11: Tests for systemic toxicity (ISO 10993-11:2017)
  • UNE-EN ISO 10993-16:2018 Biological evaluation of medical devices - Part 16: Toxicokinetic study design for degradation products and leachables (ISO 10993-16:2017)
  • UNE-EN ISO 10993-12:2022 Biological evaluation of medical devices - Part 12: Sample preparation and reference materials (ISO 10993-12:2021)
  • UNE-EN ISO 10993-10:2023 Biological evaluation of medical devices - Part 10: Tests for skin sensitization (ISO 10993-10:2021)
  • UNE-EN ISO 10993-7:2009/AC:2010 Biological evaluation of medical devices - Part 7: Ethylene oxide sterilization residuals - Technical Corrigendum 1 (ISO 10993-7:2008/Cor 1:2009)
  • UNE-EN ISO 10993-4:2018 Biological evaluation of medical devices - Part 4: Selection of tests for interactions with blood (ISO 10993-4:2017)

Malaysia Standards, Biology Triple Evaluation

  • MS 1497-2000 Methods of biological evaluation of the efficacy of repellent-bioassay method for mosquito repellent on human skin

American National Standards Institute (ANSI), Biology Triple Evaluation

  • ANSI/AAMI BE83-2006 Biological evaluation of medical devices - Part 18: Chemical characterization of materials
  • ANSI/AAMI/ISO 10993-5:2009 Biological evaluation of medical devices - Part 5: Tests for in vitro cytotoxicity
  • BS EN ISO 10993-15:2023 Biological evaluation of medical devices Identification and quantification of degradation products from metals and alloys (British Standard)

Professional Standard - Agriculture, Biology Triple Evaluation

AENOR, Biology Triple Evaluation

  • UNE-EN ISO 10993-1:2010 Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process (ISO 10993-1:2009)
  • UNE-EN ISO 10993-2:2007 Biological evaluation of medical devices - Part 2: Animal welfare requirements (ISO 10993-2:2006)
  • UNE-EN ISO 10993-18:2009 Biological evaluation of medical devices - Part 18: Chemical characterization of materials (ISO 10993-18:2005)
  • UNE-EN ISO 10993-7:2009 Biological evaluation of medical devices - Part 7: Ethylene oxide sterilization residuals (ISO 10993-7:2008)
  • UNE-EN 455-3:2015 Medical gloves for single use - Part 3: Requirements and testing for biological evaluation
  • UNE-EN ISO 10993-11:2009 Biological evaluation of medical devices - Part 11: Tests for systemic toxicity (ISO 10993-11:2006)
  • UNE-EN ISO 10993-16:2010 Biological evaluation of medical devices - Part 16: Toxicokinetic study design for degradation products and leachables (ISO 10993-16:2010)
  • UNE-EN ISO 10993-5:2009 Biological evaluation of medical devices - Part 5: Tests for in vitro cytotoxicity (ISO 10993-5:2009)
  • UNE-EN ISO 10993-14:2009 Biological evaluation of medical devices - Part 14: Identification and quantification of degradation products from ceramics (ISO 10993-14:2001)
  • UNE-EN ISO 10993-17:2009 Biological evaluation of medical devices - Part 17: Establishment of allowable limits for leachable substances (ISO 10993-17:2002)
  • UNE-EN ISO 10993-3:2015 Biological evaluation of medical devices - Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity (ISO 10993-3:2014)
  • UNE-EN ISO 10993-10:2013 Biological evaluation of medical devices - Part 10: Tests for irritation and skin sensitization (ISO 10993-10:2010)
  • UNE-EN ISO 10993-12:2013 Biological evaluation of medical devices - Part 12: Sample preparation and reference materials (ISO 10993-12:2012)
  • UNE-EN ISO 10993-6:2017 Biological evaluation of medical devices - Part 6: Tests for local effects after implantation (ISO 10993-6:2016)

国家药监局, Biology Triple Evaluation

  • YY/T 1775.1-2021 Biological Evaluation of Absorbable Medical Devices Part 1: Guidelines for Absorbable Implants

RO-ASRO, Biology Triple Evaluation

  • STAS SR EN 30993-1-1996 Biological evaluation of medical devices -Part 1: Guidance on selection of tests
  • STAS SR EN 30993-3-1996 Biological evaluation of medical devices - Part 3: Tests for genotoxicity, carcinogenity and reproductive toxicity

Shaanxi Provincial Standard of the People's Republic of China, Biology Triple Evaluation

  • DB61/T 999.12-2015 Guiding principles and test requirements for functional evaluation of health care products Part 12: Animal tests for functional evaluation of women's health care products

CH-SNV, Biology Triple Evaluation

  • SN EN ISO 10993-23:2021 Biological evaluation of medical devices - Part 23: Tests for irritation (ISO 10993-23:2021)
  • SN EN ISO 10993-12:2021 Biological evaluation of medical devices - Part 12: Sample preparation and reference materials (ISO 10993-12:2021)

Lithuanian Standards Office , Biology Triple Evaluation

  • LST EN ISO 10993-23:2021 Biological evaluation of medical devices - Part 23: Tests for irritation (ISO 10993-23:2021)
  • LST EN 455-3-2007 Medical gloves for single use - Part 3: Requirements and testing for biological evaluation
  • LST EN ISO 10993-1:2021 Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process (ISO 10993-1:2018, including corrected version 2018-10)
  • LST EN ISO 10993-12:2021 Biological evaluation of medical devices - Part 12: Sample preparation and reference materials (ISO 10993-12:2021)

PL-PKN, Biology Triple Evaluation

  • PN-EN ISO 10993-23-2021-08 E Biological evaluation of medical devices -- Part 23: Tests for irritation (ISO 10993-23:2021)
  • PN-EN ISO 10993-1-2021-06 E Biological evaluation of medical devices -- Part 1: Evaluation and testing within a risk management process (ISO 10993-1:2018, including corrected version 2018-10)

中华人民共和国国家质量监督检验检疫总局、中国国家标准化管理委员会, Biology Triple Evaluation

  • GB/T 16886.10-2017 Biological evaluation of medical devices—Part 10: Tests for irritation and skin sensitization
  • GB/T 16886.12-2017 Biological evaluation of medical devices—Part 12:Sample preparation and reference materials
  • GB/T 16886.9-2017 Biological evaluation of medical devices—Part 9: Framework for identification and quantification of potential degradation products
  • GB/T 16886.13-2017 Biological evaluation of medical devices—Part 13: Identification and quantification of degradation products from polymeric medical devices

API - American Petroleum Institute, Biology Triple Evaluation

  • API PUBL 45811-1993 Evaluation Technologies for the Treatment of Petroleum Project Marketing Terminal Wastewater (Publication 4581) Appendices: Analytical Results and Bioassay Results

AT-ON, Biology Triple Evaluation

  • OENORM EN ISO 10993-1:2021 Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process (ISO 10993-1:2018, including corrected version 2018-10)
  • OENORM EN ISO 10993-12:2021 Biological evaluation of medical devices - Part 12: Sample preparation and reference materials (ISO 10993-12:2021)

BE-NBN, Biology Triple Evaluation

  • NBN EN 30993-6-1995 Biological evaluation of medical devices - Part 6 : Tests for local effects after implantation (ISO 10993-6:1994)




Copyright ©2007-2023 ANTPEDIA, All Rights Reserved